Platelet BioGenesis' Grant - II Round

Platelet BioGenesis raised a round of funding on January 13, 2017. Investors include National Institute of Allergy and Infectious Diseases.

Platelet BioGenesis is a pre-clinical stage biotech company that was spun out of Harvard in 2014 to produce donor-independent human platelets from pluripotent stem cells Platelet BioGenesis has develo…

Articles about Platelet BioGenesis' Grant - II Round: